TOT BIOPHARM International Co. Ltd. (HK:1875) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
TOT BIOPHARM International Co. Ltd. is set to adopt a new 2024 Restricted Share Award Scheme to incentivize employees and attract talent, replacing the nearly exhausted 2020 scheme. The new plan, which will allow for grants with both new and existing shares, is pending shareholder and Listing Committee approval. A supplemental circular and notice for the Annual General Meeting will be published to propose the necessary resolutions for adoption.
For further insights into HK:1875 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue